CEA Industries Inc. (Nasdaq: BNC), a public company positioned around a sizable BNB treasury, has become the focal point of a governance dispute after investor YZi Labs accused 10X Capital and director Hans Thomas of failing to meet U.S. Securities and Exchange Commission disclosure requirements. At a high level, the conflict is about stewardship: who controls the decision rights and oversight mechanisms around a concentrated crypto treasury inside a public-company wrapper.
The dispute escalated from late 2025 into February 2026 through formal letters, filings, and public statements, creating a governance overhang that can influence both valuation and counterparty perception. When a company’s strategic identity is effectively its treasury, governance friction becomes a balance-sheet risk rather than a purely legal distraction.
— YZi Labs (@yzilabs) February 18, 2026
Allegations centered on ownership disclosure and director reporting
YZi Labs claims 10X Capital breached Sections 13(d) and 16(a) of the Securities Exchange Act by not reporting beneficial ownership after it allegedly crossed the 5% threshold in late 2025, and it further alleges Hans Thomas failed to file the required Form 3 to disclose initial director ownership. YZi’s position frames disclosure discipline as a non-negotiable control requirement for anyone influencing a public-company treasury strategy.
YZi Labs’ investment partner Alex Odagiu made the argument explicitly, stating that SEC disclosure rules are not optional and asserting that anyone unable to manage timely Section 16 filings and clear ownership disclosure should not be managing a public company. That language is designed to turn a technical filing dispute into a legitimacy challenge about board fitness and manager suitability.
CEA Industries, for its part, publicly rejected elements of the campaign, stating on February 13 that it was “fully compliant” with Nasdaq rules and calling earlier allegations “false and reckless.” The rebuttal signals that the company is treating the matter as an active corporate contest, not a quiet compliance clean-up.
Defensive measures and an attempt to reset the management contract
As the conflict intensified, the board adopted a shareholder rights plan commonly referred to as a poison pill and implemented bylaw amendments aimed at limiting rapid shifts in control. These tools are classic defensive governance mechanisms intended to slow a potential influence campaign and force engagement on the board’s terms.
In parallel, the board moved to amend the Asset Management Agreement with 10X Capital, proposing lower fees, a shorter contract duration, and more flexible termination rights, describing the changes as the output of a comprehensive review. In governance terms, this is a direct effort to reprice and rebalance the manager relationship while the legitimacy of that relationship is being contested.
The text also notes that YZi Labs confirmed a previously undisclosed side agreement that limited amendments had been terminated, which the board argues enables contract changes that were previously constrained. That detail matters because it reframes the renegotiation as newly feasible rather than purely opportunistic.
This dispute lands differently than a typical activist fight because the core asset is a concentrated crypto treasury, where decision rights, custody posture, and risk parameters are central to the investment thesis. The operational question is not abstract governance policy; it is who directs allocation and risk tolerance for the BNB holdings and under what oversight.
The situation also sits at the intersection of federal disclosure obligations and state corporate law, with the 5% threshold driving U.S. reporting duties while Nevada incorporation shapes shareholder rights and governance remedies such as board challenges or consent solicitations. That split creates a dual-track risk: regulatory compliance questions on one side and corporate-control mechanics on the other.
The most likely path is additional filings, further public positioning, and continued renegotiation around the 10X agreement as YZi Labs pursues representation and the board advances its defensive and contractual agenda. The strategic outcome will be measured in who ultimately holds the steering wheel over the BNB treasury, because that decision will drive operational risk for counterparties and governance risk for investors.
